Daily Dose Maintenance Inhalers
Links shared publicly online about this topic
Aradigm Doses First Patient In Its Second Phase 2b Clinical Trial Of Inhaled Liposomal Ciprofloxacin In Bronchiectasis Patients
medicalnewstoday.com — “Aradigm Corporation (OTCBB:ARDM) (the Company) announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an” View full resource at medicalnewstoday.com
Most Recently Shared on February 25, 2010 at 3:07 pm By:
Aradigm Doses First Patient In Its Second Phase 2b Clinical Trial Of Inhaled Liposomal Ciprofloxacin In Bronchiectasis... http://mnt.to/3y6r
Aradigm Presents Results Supporting Once-Daily Dosing With Its Inhaled Liposomal Ciprofloxacin Formulations at the 2010 European Respiratory Society (ERS) Annual Congress - Drugs.com MedNews
drugs.com — “Sep 17, 2010 - Aradigm Corporation (OTCBB ARDM) ( Aradigm ) today announced it is presenting data on September 22, 2010, from its Phase 1 studies at the ERS Ann” View full resource at drugs.com
Most Recently Shared on September 17, 2010 at 1:03 pm By:
Drugs and Devices OW OW Health
Aradigm Presents Results Supporting Once-Daily Dosing With Its Inhaled Liposomal Ciprofloxacin Formulations a... http://bit.ly/d6gzhP #drug
Aradigm initiates dosing in Phase 2b trial of inhaled liposomal ciprofloxacin formulations in BE patients
news-medical.net — “Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no” View full resource at news-medical.net
Most Recently Shared on February 23, 2010 at 1:32 pm By:
Aradigm initiates dosing in Phase 2b trial of inhaled liposomal ciprofloxacin formulations in BE patients: Aradigm... http://bit.ly/abhAXg
Infectious Disease News - Pharmacokinetics of and Short-Term Virologic Response to Low-Dose 400-Milligram Once-Daily Raltegravir Maintenance Therapy |3984254
mdlinx.com — “Infectious Disease Medical Article: Pharmacokinetics of and Short-Term Virologic Response to Low-Dose 400-Milligram Once-Daily Raltegravir Maintenance Therapy” View full resource at mdlinx.com
Most Recently Shared on March 20, 2012 at 4:40 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Pharmacokinetics of and Short-Term Virologic Response to Low-Dose 400-Milligram Once-Daily Raltegravir Maint... http://t.co/1yeo2fwy #ID
The Ritedose Corporation Announces the Voluntary Nationwide Recall of 0.083% Albuterol Sulfate Inhalation Solution, 3 mL Due to Mislabeled Unit Dose Vials
fda.gov — “The Ritedose Corporation is conducting a voluntary recall of 0.083% Albuterol Sulfate Inhalation Solution, 3 mL (in 25, 30, and 60 unit dose vials). This product is a prescription inhalation solution, administered via nebulization, for the treatment and maintenance of acute asthma exacerbations and exercise induced asthma in children and adults.” View full resource at fda.gov
Most Recently Shared on January 3, 2011 at 10:27 pm By:
Texas Children's Hospital and Children's Hospital
RT @kidsindanger: Use Albuterol with a nebulizer? Check this recall: http://www.fda.gov/Safety/Recalls/ucm238528.htm
Inhaled steroids don't help asthma flare-ups | Reuters
reuters.com — “NEW YORK (Reuters Health) - Doubling the dose of inhaled steroids doesn't appear to dampen asthma attacks, despite the practice being recommended by many doctors, Canadian researchers said Thursday. More” View full resource at reuters.com
Most Recently Shared on October 7, 2010 at 10:30 pm By:
Hisham Rana, MD Doctor and Physician
Study: Inhaled steroids don't help asthma flare-ups (The Cochrane Library) http://reut.rs/cK9TiW - #health
Ritedose Corp. Recalls 0.083% Albuterol Sulfate Inhalation Solution
usrecallnews.com — “The Ritedose Corporation is recalling 0.083% Albuterol Sulfate Inhalation Solution, 3 mL (in 25, 30, and 60 unit dose vials). This product is a prescription inhalation solution, administered via nebulization, for the treatment and maintenance of acute asthma exacerbations and exercise induced asthma in children and adults.” View full resource at usrecallnews.com
Most Recently Shared on January 5, 2011 at 7:20 pm By:
Ritedose Corp. Recalls 0.083% Albuterol Sulfate Inhalation Solution http://f.ast.ly/9XRjK
Asthma Attacks Not Helped by More Inhaled Steroids (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Increasing the maintenance dose of inhaled corticosteroid at the beginning of an asthma attack did not lessen the need for systemic corticosteroids, according to a Cochrane review.” View full resource at qualitypointtech.net
Most Recently Shared on October 8, 2010 at 8:12 pm By:
Asthma Attacks Not Helped by More Inhaled Steroids (CME/CE): (MedPage Today) -- Increasing the maintenance dose of... http://bit.ly/abPnGK
In Toddlers, No Difference Found Between Intermittent And Daily Wheezing Treatment
medicalnewstoday.com — “Pediatricians often treat young children who have frequent bouts of wheezing with a daily dose of an inhaled steroid to keep asthma symptoms at bay. But results of a recent study are likely to cha” View full resource at medicalnewstoday.com
Most Recently Shared on November 30, 2011 at 8:05 am By:
In Toddlers, No Difference Found Between Intermittent And Daily Wheezing Treatment http://t.co/gIoCFf0e #asthma
Almirall and Forest Announce Positive Results from the ATTAIN Phase III Study of Aclidinium Bromide and the Phase IIb Studies with the Fixed Dose Combination with Formoterol in Moderate to Severe COPD Patients - Drugs.com MedNews
drugs.com — “Jan 4, 2011 - Almirall, S.A. (ALM.MC) and Forest Laboratories, Inc. (NYSE FRX) today announced positive top-line results of ATTAIN, a six month double-blind pla” View full resource at drugs.com
Most Recently Shared on January 5, 2011 at 3:16 pm By:
Drugs and Devices OW OW Health
Almirall and Forest Announce Positive Results from the ATTAIN Phase III Study of Aclidinium Bromide and th... http://bit.ly/gsEsID #drug
Medical News: Daily Asthma Tx Not Needed for Wheezing Tots - in Pediatrics, Asthma from MedPage Today
medpagetoday.com — “Intermittent inhaled corticosteroids may be as good as daily dosing at preventing asthma attacks in toddlers with wheezing episodes, a randomized trial determined.” View full resource at medpagetoday.com
Most Recently Shared on November 23, 2011 at 10:39 pm By:
allergydropz Surgeon, ENT Doctor, Physician, and Doctor
Medpage Today: Daily Asthma Tx Not Needed for Wheezing Tots (CME/CE) http://t.co/ziIj224Q Full http://t.co/mqf6jVIh
Phase II Study Showed Switching ACS-PCI Patients To Effient®/aspirin From Plavix®/aspirin Regimen Reduced Maximum Platelet Aggregation
medicalnewstoday.com — “A study evaluating the level of platelet aggregation achieved after switching from Plavix® (clopidogrel) 75 mg once-daily maintenance dosing plus aspirin to Effient® (prasugrel) 10 mg onc” View full resource at medicalnewstoday.com
Most Recently Shared on September 14, 2010 at 1:38 pm By:
MNT Clinical Trials Health News
Phase II Study Showed Switching ACS-PCI Patients To Effient®/aspirin From Plavix®/aspirin Regimen Reduced Maxi... http://mnt.to/3JHJ
Phase II Study Showed Switching ACS-PCI Patients to Effient/aspirin from Plavix/aspirin Regimen Reduced Maximum Platelet Aggregation After One Week - Drugs.com MedNews
drugs.com — “PARSIPPANY, N.J. and INDIANAPOLIS, Sept. 13 A study evaluating the level of platelet aggregation achieved after switching from Plavix (clopidogrel) 75 mg once-d” View full resource at drugs.com
Most Recently Shared on September 14, 2010 at 2:17 pm By:
Drugs and Devices OW OW Health
Phase II Study Showed Switching ACS-PCI Patients to Effient/aspirin from Plavix/aspirin Regimen Reduced Maxim... http://bit.ly/cGnt1f #drug
FDA Approves Spiriva HandiHaler for the Reduction of COPD Exacerbations
drugs.com — “Spiriva HandiHaler (tiotropium bromide) is used for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Includes Spiriva HandiHaler side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on December 20, 2009 at 7:35 pm By:
FDA Approves Spiriva HandiHaler for the Reduction of COPD Exacerbations - http://bit.ly/8NzjMW
Schering-Plough Europe Withdraws Its Marketing Authorisation Application For Zenhale (mometasone Furoate/formoterol Fumarate)
medicalnewstoday.com — “The European Medicines Agency has been formally notified by Schering-Plough Europe of its decision to withdraw its application for a centralised marketing authorisation for the medicine Zenhale (m” View full resource at medicalnewstoday.com
Most Recently Shared on November 10, 2010 at 2:25 pm By:
Schering-Plough Europe Withdraws Its Marketing Authorisation Application For Zenhale (mometasone Furoate/formoterol Fu... http://mnt.to/3MkG
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MNT Asthma News
The latest asthma and respiratory news published daily. Articles from research centers, universities and prestigious journals.
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
News-Medical.Net
Medical News from Around the World
Advertisement
